SMECTIDRAT, created in 1984 (France), from 306 sister brands and 4958 competing brands. The SMECTIDRAT brand is owned by Ipsen, a company listed in Paris. The ISIN, the company's International Securities Identification Number, is FR0010259150. SMECTIDRAT belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
Ipsen
(SMECTIDRAT)
over 5 years*
EUR 122.85